Analysis of binding properties of phosphoinositide 3-kinase through In silico molecular docking

Journal of Proteomics and Bioinformatics

Volumn 2, Issue 6, 2009, Pages 274-284

  Daisy, P ^a   Sasikala, R ^a   Ambikar, A ^a  

^a HOLY CROSS COLLEGE   (India)

Author keywords

In silico binding affinities; Molecular docking; PI 3 kinase inhibitors

Indexed keywords

EID: 75649102516     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.1000086     Document Type: Article

References (49)

1. Amit KT, Madhumita R, Bhattacharya RK "Natural products as inducers of apoptosis: Implication for cancer therapy and prevention".
2. Ali IU, Schriml LM, Dean M (1999) Mutational spectra ofPTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91: 1922-1932.
3. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, (1995) Molecular alterations ofthe AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64: 280-285.
4. Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, (2006) An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression. J Med Chem 49:3116-3135.
5. Brooijmans N, Kuntz ID (2003) Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct 32: 335-373.
6. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF (2008) The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-98.
7. Chang RS, Ding L, Chen GQ, Pan QC, Zhao ZL, (1991) Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 197: 59-66.
8. Congreve M, Murray CW, Blundell TL (2005) Structural biology and drug discovery. Drug Discov Today 10: 895-907.
9. Fang XK, Gao J, Zhu DN (2008) Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci 82: 615-22.
10. Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DB, (1995) Molecular Recognition of the Inhibitor AG-1343 by HIV-1 Protease: Conformationally Flexible Docking by Evolutionary Programming. Chemistry & Biology 2: 317.
11. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, et al. (1999) Flavonoids and the inhibition of PKC and PI 3-kinase. General Pharmacology 32: 279-286.
12. Gehlhaar DK, Bouzida D, Rejto PA (1999) Rational Drug Design: Novel Methodology and Practical Applications. American Chemical Society 292-311.
13. Irwin JJ, Lorber DM, McGovern SL, Wei B, Shoichet BK (2002) Computational Nanoscience and Nanotechnology ISBN 0-9708275-6-3.
14. Jain AN (1996) Scoring noncovalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Design 10: 427-440.
15. Jeong JC, Kim MS, Kim TH, Kim YK (2009) Kaempferol induces cell death through ERK and Aktdependent down-regulation of XIAP and survivin in human glioma cells. Neurochem Res May 34: 991-1001.
16. Krammer A, Kirchhoff PD, Jiang X, Venkatachalam CM, Waldman M (2005) LigScore: a novel scoring function for predicting binding affinities. J Mol Graph Model 23: 395-407.
17. Kim EJ, Choi CH, Park JY, Kang SK, Kim YK (2008) Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res 33: 971-9.
18. Labbé D, Provençal M, Lamy S, Boivin D, Gingras D, (2009) The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J Nutr 139: 646-52.
19. Lee SH, Cekanova M, Baek SJ (2008) Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcino 47: 197-208.
20. López-Lázaro M (2009) Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9: 31-59.
21. Lin FL, Wu SJ, Lee SC, (2009) Antioxidant, antioedema and analgesic activities of Andrographis paniculata extracts and their active constituent andrographolide. Phytother Res.
22. Masuda Y, Kikuzaki H, Hisamoto M, Nakatani N (2004) Antioxidant properties of gingerol related compounds from ginger. Biofactors 21: 293-6.
23. Moore SM, Rintoul RC, Walker TR, Chilvers ER, Haslett C, (1998) The presence of a constitutively-active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 58: 5239-5247.
24. Muegge I and Martin YC (1999) A General and Fast Scoring Function for Protein-Ligand Interactions: A Simplified Potential Approach. J Med Chem 42: 791.
25. Muegge I (2006) PMF Scoring Revisited. J Med Chem 49: 5895-5902.
26. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, (1999) Up-regulation ofAkt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274: 21528-21532.
27. NCBI-PubChem Compound database. [http:// pubchem.ncbi.nlm.nih.gov/]
28. Noguchi M and Kinowaki K (2008) PI3K-AKT network roles in infectious diseases Kansenshogaku Zasshi 82: 161-7.
29. Park M, Bae J, Lee DS (2008) Nov Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria. Phytother Res 22: 1446-9.
30. Pierre PM, Peter MT, Yu S, Rahman SMJ, Yildiz P, (2004) Early Involvement of the Phosphatidylinositol 3-Kinase/Akt Pathway in Lung Cancer Progression. Am J Respir Crit Care Med 170: 1088-1094.
31. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, (1994) Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54: 2419-2423.
32. Protein Data Bank. [http://www.rcsb.org/pdb/home/home.do]
33. Pubmed
34. Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R (2003) Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol 147-58.
35. Sawyer JS, Anderson BD, Beight DW, Campbell RM, Jones ML, (2003) Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. J Med Chem 46: 3953-3956.
36. Stein RC (2001) Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr Relat Cancer 8: 237-248.
37. Sekiya K, Ohtani A, Kusano S (2004) Enhancement of insulin sensitivity in adipocytes by ginger 22: 153-6.
38. Shayesteh L, Lu Y, Kuo W, Baldocchi R, Godfrey T, (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21: 99-102.
39. Singh J, Chuaqui CE, Boriack-Sjodin PA, Lee WC, Pontz T, (2003) Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI). Bioorg Med Chem Lett 13: 4355-4359.
40. Tereschuk ML, Baigorí MD, De Figueroa LI, Abdala LR (2004) Flavonoids from Argentine Tagetes (Asteraceae) with antimicrobial activity. Methods Mol Biol 268: 317-30.
41. Tsai HR, Yang LM, Tsai WJ, Chiou WF (2004) Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Eur J Pharmacol 498: 45-52.
42. Vanhaesebroeck B, Waterfield MD (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253: 239-254.
43. Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) LigandFit: A Novel Method for the Shape-Directed Rapid Docking of Ligands to Protein Active Sites. J Mol Graph Modell 21: 289-307.
44. Verma AR, Vijayakumar M, Mathela CS, Rao CV (2009) In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Food Chem Toxicol.
45. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
46. Woscholski R, Kodaki T, McKinnona M, Waterfield MD, Parker PJ (1994) A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase. FEBS Letters 342: 109-114.
47. Yu BC, Hung CR, Chen WC, Cheng JT (2003) Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med 69: 1075-9.
48. Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, (2000) Frequent activation ofAKT2 and induction ofapoptosis by inhibition Of phosphoinositide-3-OH kinase/ Akt pathway in human ovarian cancer. Oncogene 19: 2324-2330.
49. Zhong YC (2006) Effect of three flavones on enzyme activity of recombinant human phosphoinositide 3-kinase p110beta catalytic subunit 29: 33-6.